Aehr director gifts 15,000 shares to trusts

Aehr Test Systems director Howard T. Slayen reported gifting 15,000 shares of common stock to family trusts.

Rhea-AI Filing Summary

Aehr Test Systems director Howard T. Slayen reported gifting 15,000 shares of common stock to family trusts. On 02/04/2026, he made three separate transfers of 5,000 shares each at a reported price of $0 per share, reflecting non-cash gifts.

The gifts went to the Leila James Slayen Trust, the Allison Elizabeth Slayen Trust, and the Max William Slayen Trust. After these transactions, Slayen beneficially owned 203,328 shares of Aehr Test Systems common stock, which the filing states includes shares subject to unvested restricted stock units.

Insider Trade Summary

15,000 shares gifted

Gift 3 txns

Insider SLAYEN HOWARD T

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	5,000	$0.00	$0.00
Gift	Common Stock	5,000	$0.00	$0.00
Gift	Common Stock	5,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 203,328 shares (Direct)

Footnotes (4)

1. F1. The shares were gifted to the Leila James Slayen Trust.
2. F2. The shares were gifted to the Allison Elizabeth Slayen Trust.
3. F3. The shares were gifted to the Max William Slayen Trust.
4. F4. The amount reported includes shares subject to unvested restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AEHR director Howard T. Slayen report?

Howard T. Slayen reported three stock gifts. On 02/04/2026, he transferred three blocks of 5,000 Aehr Test Systems common shares each, all at a stated price of $0 per share, reflecting non-cash gifts to family trusts.

How many AEHR shares did Howard T. Slayen gift on February 4, 2026?

He gifted a total of 15,000 AEHR shares. The Form 4 shows three separate dispositions of 5,000 common shares each on 02/04/2026, all coded as gifts and priced at $0 per share, directed to three named trusts.

Who received the AEHR shares gifted by director Howard T. Slayen?

Three family trusts received the AEHR shares. The filing explains that 5,000 shares were gifted to the Leila James Slayen Trust, 5,000 to the Allison Elizabeth Slayen Trust, and 5,000 to the Max William Slayen Trust on 02/04/2026.

How many AEHR shares does Howard T. Slayen own after the reported gifts?

He beneficially owns 203,328 AEHR shares after the gifts. The Form 4 states this post-transaction balance of common stock and notes that the reported amount includes shares subject to unvested restricted stock units held by Slayen.

What is Howard T. Slayen’s relationship to Aehr Test Systems (AEHR)?

Howard T. Slayen is a director of Aehr Test Systems. The Form 4 identifies him as a reporting person with the box for “Director” checked, and does not indicate officer or 10% owner status for this insider at the time of the filing.

Were the AEHR stock gifts by Howard T. Slayen cash transactions?

No, the AEHR stock gifts were non-cash transfers. Each of the three dispositions of 5,000 common shares on 02/04/2026 shows a transaction price of $0 per share, consistent with shares being transferred as gifts to the specified family trusts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 08:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SLAYEN HOWARD T

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CA 94539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		G		5,000(1)	D	$0	213,328	D
Common Stock	02/04/2026		G		5,000(2)	D	$0	208,328	D
Common Stock	02/04/2026		G		5,000(3)	D	$0	203,328(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were gifted to the Leila James Slayen Trust.

2. The shares were gifted to the Allison Elizabeth Slayen Trust.

3. The shares were gifted to the Max William Slayen Trust.

4. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.